Amedisys to Present at the 25th Annual Oppenheimer Healthcare Conference
December 10 2014 - 11:00AM
Amedisys, Inc. (Nasdaq:AMED), one of America's leading healthcare
at home companies, today announced that Dale E. Redman, Interim
Chief Financial Officer, will present at the 25th Annual
Oppenheimer Healthcare Conference in New York, NY on Thursday,
December 11, 2014.
The presentation will begin at 8:35 a.m. Eastern. To access a
live webcast of the Amedisys presentation, please log on through
our website at http://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. (Nasdaq:AMED) is a leading healthcare at home
company delivering personalized home health and hospice care to
more than 360,000 patients each year. More than 2,200 hospitals and
61,900 physicians nationwide have chosen Amedisys as a partner in
post-acute care. Amedisys is focused on delivering the care that is
best for our patients, whether that is home-based recovery and
rehabilitation after an operation or injury, care focused on
empowering them to manage a chronic disease, palliative care for
those with a terminal illness, or hospice care at the end of life.
Amedisys also has the industry's first-ever nationwide Care
Transitions program, designed to reduce unnecessary hospital
readmissions through patient and caregiver health coaching and care
coordination, which starts in the hospital and continues throughout
completion of the patient's home health plan of care. For more
information about the Company, please visit:
http://www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, analyst presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. We will also use our website to expedite
public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing
with the Securities and Exchange Commission ("SEC") disclosing the
same information. In addition, we make available on the Investor
Relations subpage of our website (under the link "SEC filings")
free of charge our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, ownership reports on
Forms 3, 4 and 5 and any amendments to those reports as soon as
practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our
Code of Ethical Business Conduct and the charters for the Audit,
Compensation, Nominating and Corporate Governance, Quality of Care
and Compliance and Ethics Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
CONTACT: Amedisys, Inc.
David Castille
Managing Director, Finance
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024